What question did this study set out to answer?

This research aims to investigate how certain drugs affect NKG2D levels in immune cells from Behçet syndrome patients.

March 21, 2026

In vitro pharmacological modulation of NKG2D expression in immune cells from Behçet syndrome patients

Puntos clave

This research aims to investigate how certain drugs affect NKG2D levels in immune cells from Behçet syndrome patients.
In vitro experiments using immune cells from Behçet syndrome patients and control individuals.
Application of dexamethasone and colchicine to assess their effects on NKG2D expression.
Comparative analysis of immune responses between patients and controls.
Drugs reduced NKG2D expression in immune cells from patients.
Differential responses to dexamethasone and colchicine were observed between patient and control groups.

Resumen

Drugs used in the management of BS reduced NKG2D expression, potentially decreasing the activation of cytotoxic cells. Immune cells from BS patients responded differently to dexamethasone and colchicine compared to those from CTR.

Connected Papers

Building similarity graph...

Analyzing shared references across papers

Discussion

Authors

Martina Bonacini

F Muratore

Laura Albertazzi

Journals

Clinical & Experimental Immunology

Actions

Institutions

University of Modena and Reggio Emilia

Azienda Sanitaria Unità Locale di Reggio Emilia

References and Citations

Connected Papers

Building similarity graph...

Analyzing shared references across papers

In vitro pharmacological modulation of NKG2D expression in immune cells from Behçet syndrome patients

Puntos clave

Resumen

Citation Network

Connected Papers

Discussion

Authors

Journals

Actions

Institutions

References and Citations

Citation Network

Connected Papers

Discussion

Cite this study

Also consider